Combining structure-based drug design and pharmacophores

The Protein Data Bank

Helen M. Berman · Nucleic Acids Research · 2000 · 39.8K citations

Life Sciences, Biochemistry, Bioinformatics +10

Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors

Jianping Ding, Kalyan Das, Henri Moereels et al. · Nature Structural & Molecular Biology · 1995 · 299 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +16

Developing a Dynamic Pharmacophore Model for HIV-1 Integrase

Heather A. Carlson, Kevin M. Masukawa, Kathleen Rubins et al. · Journal of Medicinal Chemistry · 2000 · 259 citations · Full text

Life Sciences, Biophysics, Pharmacology +17

Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance 1 1Edited by J. Karn

Y. Hsiou, Kalyan Das, Jianping Ding et al. · Journal of Molecular Biology · 1998 · 123 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +17

Binding of the Second Generation Non-nucleoside Inhibitor S-1153 to HIV-1 Reverse Transcriptase Involves Extensive Main Chain Hydrogen Bonding

Jingshan Ren, Charles E. Nichols, Louise E. Bird et al. · Journal of Biological Chemistry · 2000 · 121 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +17